Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) WilsonEncourages Investors Who Suffered Significant Losses In MoonLake To Contact Him Directly To Discuss Their Options
If you suffered significant losses in MoonLake stock or options and would like to discuss your legal rights,call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330(Ext. 1310).
[You may also click here for additional information]
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX).
https://mma.prnewswire.com/media/2457438/Faruqi_Logo.jpg
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
Moonlake Immunotherapeutics saw its shares plummet over 80% on Monday after disappointing results from two late-stage trials of its experimental drug, sonelokimab, for hidradenitis suppurativa. While one study showed a statistically significant improvement over placebo, the margin of benefit fell short of investor expectations. The second trial failed to meet its primary endpoint entirely, with the company citing an unexpectedly high placebo response. The underwhelming data has cast doubt on the drug's regulatory path and commercial potential, prompting skepticism from analysts and a sharp market sell-off.
To learn more about the MoonLake investigation, go to www.faruqilaw.com/MLTX or callFaruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330(Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Attorney Advertising. The law firm responsible for this advertisement isFaruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
https://mma.prnewswire.com/media/2745617/Faruqi__Faruqi_LLP_James_Josh_Wilson.jpg
https://edge.prnewswire.com/c/img/favicon.png?sn=NY88540&sd=2025-10-03
View original content to download multimedia:https://www.prnewswire.com/news-releases/mltx-investor-alert-faruqi–faruqi-llp-investigates-claims-on-behalf-of-investors-of-moonlake-immunotherapeutics-302574418.html
SOURCE Faruqi & Faruqi, LLP
https://rt.newswire.ca/rt.gif?NewsItemId=NY88540&Transmission_Id=202510031115PR_NEWS_USPR_____NY88540&DateId=20251003